Ligand Pharmaceuticals Inc (NASDAQ:LGND)

Delayed Data
As of Aug 12
 +4.50 / +4.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 158.50, with a high estimate of 310.00 and a low estimate of 130.00. The median estimate represents a +48.87% increase from the last price of 106.47.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -48.19%
Growthannually -57.13%


Growthquarterly -32.29%
Growthannually -35.33%
Key to the earnings and sales forecast charts.